Bill Sponsor
Senate Bill 2742
115th Congress(2017-2018)
SARMs Control Act of 2018
Introduced
Introduced
Introduced in Senate on Apr 24, 2018
Overview
Text
Introduced
Apr 24, 2018
Latest Action
Apr 24, 2018
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2742
Congress
115
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Sponsorship by Party
Republican
Utah
Democrat
Rhode Island
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Selective Androgen Receptor Modulators Control Act of 2018 or the SARMs Control Act of 2018

This bill amends the Controlled Substances Act (CSA) to add SARMs (selective androgen receptor modulators) to schedule III. A SARM is a synthetic drug or substance that has effects similar to testosterone. A schedule III controlled substance (e.g., an anabolic steroid) has less potential for abuse than a schedule I or II substance, has a currently accepted medical use, and has low or moderate risk of dependence if abused.

The bill also:

  • authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently add a drug or substance to the definition of a SARM;
  • specifies that a felony drug offense includes an offense related to SARMs; and
  • makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a SARM that is not clearly labeled.

The bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to notify the DEA when it determines that a new dietary ingredient in a dietary supplement may contain a SARM or SARM analogue.

Text (1)
April 24, 2018
Actions (2)
04/24/2018
Read twice and referred to the Committee on the Judiciary.
04/24/2018
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:39:39 PM